Relay Medical Corp. develops a new home and small business mobile testing solution
by CM Staff
The Company is now involved in discussions and early-stage engagements with potential strategic partners while continuing product development.
TORONTO — On Aug. 26, Relay Medical Corp. reports on the development of a new home and small business testing system based on the Company’s Pharmatrac platform. The universal device and mobile app allow for use of lateral flow diagnostic kits, including COVID-19 antigen and antibody tests.
The new mobile application and device shares the intellectual property and technology synergies between Relay’s medication management device, Pharmatrac, and FRR’s rapid testing and tracking platform, Fionet, which has recently been deployed in a wide variety of settings including Airports1, Sporting Events, and with USAID to 144 remote locations in Africa.
“The dynamics of testing evolves each day and we are designing solutions to evolve in tandem with them. The Fionet platform has been proven in the field and we are now pleased to expand the functionality for the SMB and home markets,” said Yoav Raiter, CEO, Relay Medical Corp. “The future is in safe, convenient, affordable and compliant testing – and we are well positioned to be part of it.”
The Company is now involved in discussions and early-stage engagements with potential strategic partners while continuing product development, conducting demos, small pilots, and internal trials to refine custom applications specific to industry and regional integrations.
The new mobile and device application utilizes the core machine vision and AI functionalities of Pharmatrac to improve testing compliance and quality in moderate throughput settings. In many regions, home testing is not approved due to concerns from health authorities over compliance to testing protocols by users. Relay and FRR bring together the complementary technologies to minimize compliance risk, ensure adherence to proper Instructions For Use (IFU) of the test, and deliver lab-quality results in remote locations.The platform also enables remote healthcare professionals to review and interpret results while increasing patient accessibility and guidance if further action is required.
As health systems and governments around the world adapt to the pandemic, there is a persistent need to prevent the spread of the virus and its variants through rapid testing and isolation procedures. Rapid test kits are valuable screening tools that can identify potentially infected individuals and prevent outbreaks before they occur. The widespread use of rapid antigen testing can help society return to pre-COVID-19 activities including concerts, theatres, sporting events, and other large gatherings safely.